| +1.10 / +1.25%|
The 27 analysts offering 12-month price forecasts for Novartis AG have a median target of 96.09, with a high estimate of 108.46 and a low estimate of 71.68. The median estimate represents a +7.60% increase from the last price of 89.30.
The current consensus among 31 polled investment analysts is to Hold stock in Novartis AG. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.